SIMCERE PHARMA(02096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02096 SIMCERE PHARMA

Closed 01-21 16:08:56

11.830

+0.010

+0.08%

High12.020	Low11.630	Vol3.57M
Open11.700	D1 Closing11.820	Amplitude3.30%
Mkt Cap30.71B	Tradable Cap30.71B	Total Shares2.60B
T/O42.26M	T/O Rate0.14%	Tradable Shares2.60B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02096","market":"HK","secType":"STK","nameCN":"SIMCERE PHARMA","latestPrice":11.83,"timestamp":1768982936003,"preClose":11.82,"halted":0,"volume":3570002,"delay":0,"changeRate":0.0008460236886632645,"floatShares":2596000000,"shares":2596000000,"eps":0.291754,"marketStatus":"Closed","change":0.01,"latestTime":"01-21 16:08:56","open":11.7,"high":12.02,"low":11.63,"amount":42256849,"amplitude":0.032995,"askPrice":11.84,"askSize":23000,"bidPrice":11.83,"bidSize":8000,"shortable":3,"etf":0,"ttmEps":0.372,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769045400000},"marketStatusCode":5,"adr":0,"listingDate":1603728000000,"exchange":"SEHK","adjPreClose":11.82,"dividendRate":0.014776,"openAndCloseTimeList":[[1768959000000,1768968000000],[1768971600000,1768982400000]],"volumeRatio":0.393052,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02096/wiki","defaultTab":"wiki","newsList":[{"id":"1113833167","title":"SIMCERE PHARMA (02096) Repurchases 1.884 Million Shares for HK$22.21 Million on January 20","url":"https://stock-news.laohu8.com/highlight/detail?id=1113833167","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113833167?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:24","pubTimestamp":1768919055,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) announced that on January 20, it repurchased 1.884 million shares at a total cost of HK$22.21 million.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02096","BK1191"],"gpt_icon":0},{"id":"1160403523","title":"SIMCERE PHARMA (02096) Repurchases 4.433 Million Shares for HK$51.6328 Million on January 16","url":"https://stock-news.laohu8.com/highlight/detail?id=1160403523","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160403523?lang=en_us&edition=fundamental","pubTime":"2026-01-16 18:38","pubTimestamp":1768559907,"startTime":"0","endTime":"0","summary":"On January 16, SIMCERE PHARMA (02096) announced that the company repurchased 4.433 million shares at a cost of HK$51.6328 million.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"2603646969","title":"Simcere Pharmaceutical Group Limited (HKG:2096) Shares Could Be 48% Below Their Intrinsic Value Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2603646969","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603646969?lang=en_us&edition=fundamental","pubTime":"2026-01-16 11:05","pubTimestamp":1768532759,"startTime":"0","endTime":"0","summary":"Key Insights The projected fair value for Simcere Pharmaceutical Group is HK$22.34 based on 2 Stage Free Cash Flow to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/simcere-pharmaceutical-group-limited-hkg2096-shares-could-be","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/simcere-pharmaceutical-group-limited-hkg2096-shares-could-be","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","02096","DCF","TV","BK1583","BK4211","FCF","BK4100"],"gpt_icon":0},{"id":"1180175368","title":"SIMCERE PHARMA (02096) Repurchases 3.672 Million Shares for HK$41.9453 Million on January 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1180175368","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180175368?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:20","pubTimestamp":1768224017,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) announced that on January 12, 2026, the company repurchased 3.672 million of its own shares at a total cost of HK$41.9453 million. The repurchase price per share ranged from HK$11.1975 to HK$11.6.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"2602560968","title":"Simcere Pharmaceutical to Spin Off, List Chinese Subsidiary; Shares Down 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602560968","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602560968?lang=en_us&edition=fundamental","pubTime":"2026-01-12 12:04","pubTimestamp":1768190669,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group  plans to spin off and list its Chinese subsidiary Simcere Zaiming in Hong Kong, according to a Hong Kong bourse filing Friday.Shares of the drugmaker fell over 7% in late morning trade Monday.The firm said Simcere Zaiming had filed to list its H shares in Hong Kong and details of a global offering were yet to be finalized.The firm currently owns 83.10% of the business and said the move would lower its interest to over 50%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","02096","BK1191"],"gpt_icon":0},{"id":"1177844893","title":"HKEX Announcement Highlights | Simcere Pharma Plans to Spin Off Simcere Ming's H Shares for Separate Listing on Main Board","url":"https://stock-news.laohu8.com/highlight/detail?id=1177844893","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177844893?lang=en_us&edition=fundamental","pubTime":"2026-01-11 20:21","pubTimestamp":1768134108,"startTime":"0","endTime":"0","summary":"【Major Corporate Actions】CATL (03750): AutoFlight intends to issue an additional 34.8584 million shares. MINIMAX-WP (00100): Fully exercised the over-allotment option, involving a total of 4.3796...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052750758.USD","LU0708995583.HKD","LU0463099449.HKD","LU0561508036.HKD","LU1960683339.HKD","03938","BK1523","LU0084288322.USD","LU1880383366.USD","LU0797268264.HKD","LU1152091754.HKD","HXXD.SI","00100","LU0449509016.USD","LU0164880469.USD","LU1770036033.HKD","LU0823426480.USD","LU1981816686.USD","LU0594300419.USD","LU0117841782.USD","LU0214875030.USD","LU0320764599.SGD","LU0918141887.USD","LU1868838027.USD","LU1993786604.SGD","LU2476274308.USD","LU0918141705.HKD","LU0456827905.SGD","LU0540923850.HKD","LU2097828474.EUR","LU0149721374.USD","81810","LU0650527681.SGD","LU0531971595.HKD","LU1956131251.USD","LU0675040207.SGD","LU0348825331.USD","LU1719994722.HKD","LU0054450605.USD","LU2152927971.USD","LU1323998911.USD","BK1193","LU1303224171.USD","LU0823041008.USD","LU0871576103.HKD","BK1589","02096","LU0345776255.USD","LU2257852520.SGD","LU2097828557.USD","BK1116","BK1610","LU0531970944.HKD","LU0572944931.SGD","IE0034224299.USD","LU0254981946.USD","LU0143863198.USD","LU0417516902.SGD","BK1502","LU1813983027.USD","03750","LU1770034418.SGD","LU2778985437.USD","BK1191","LU0499858438.USD","LU0823426308.USD","LU0700851271.USD","LU0210526637.USD","SG9999002463.SGD","LU1251922891.USD","SG9999003461.SGD","LU2039709279.SGD","BK1117","LU1152091168.USD","LU0348814723.USD","LU0067412154.USD","LU1282648689.USD","01810","LU0880133367.SGD","LU0359201885.HKD","LU1808992512.USD","LU0499858602.USD","LU2097828631.EUR","LU0143863784.USD","LU1023057109.AUD","LU0348827113.USD","LU0231483743.USD","BK1615","LU0359201612.USD","LU0594300179.USD","LU0164872284.USD","LU2399975544.HKD","LU0823413587.USD","LU0823413660.USD","LU2087589342.USD","LU0456846285.SGD","LU0235996351.USD","LU0634319403.HKD","LU0823397285.USD","LU0039217434.USD","LU0605514214.HKD","BK1506","LU1188198961.HKD","LU0164865239.USD","LU0593848301.USD","LU2097828805.USD","LU0244354667.USD","LU0417516738.SGD","HK0000165453.HKD","LU0441854154.USD","BK1147","XIACY","LU0314109678.HKD","SG9999001093.SGD","LU1008478684.HKD","IE00B3M56506.USD","LU0169518387.USD","LU1720050803.USD","LU0307460666.USD","BK1575","LU1328277881.USD","LU0823038988.USD","BK1607","LU0348816934.USD","LU0611395673.USD","IE0032431581.USD","LU0327786744.USD","LU0348735423.USD","LU1807302812.USD","BK1521","LU0359202008.SGD","LU0449515922.USD","LU1105468828.SGD","LU0051755006.USD","LU0823040885.USD","LU0211977185.USD","LU0823397103.USD","LU1481107354.HKD","LU0823039010.USD","BK1618","LU0345775950.USD","LU1868837565.USD","LU1961090484.USD","LU2476274720.SGD","MIUmain","LU1880383440.USD","LU1794554557.SGD","LU0588546209.SGD","LU0326950275.SGD","BK1583","LU2226246903.HKD","LU2097828714.EUR"],"gpt_icon":1},{"id":"2602630395","title":"BRIEF-Simcere Pharmaceutical Announces Spin-Off & Separate Listing Of Simcere Zaiming Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2602630395","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602630395?lang=en_us&edition=fundamental","pubTime":"2026-01-10 01:50","pubTimestamp":1767981039,"startTime":"0","endTime":"0","summary":"BRIEF-Simcere Pharmaceutical Announces Spin-Off & Separate Listing Of Simcere Zaiming PharmaceuticalJan 9 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK:PROPOSED SPIN-OFF AND SEPARATE LISTING OF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA051:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1583","BK1191"],"gpt_icon":0},{"id":"1125028503","title":"SIMCERE PHARMA (02096) Plans to Spin Off SIMCERE RENMING's H Shares for Separate Listing on SEHK Main Board","url":"https://stock-news.laohu8.com/highlight/detail?id=1125028503","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125028503?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:20","pubTimestamp":1767968424,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) announced that the company proposes to spin off its subsidiary SIMCERE RENMING's H shares for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2602112371","title":"Simcere Pharmaceutical - Upon Completion, Co Expected to Have Interest of Over 50% in Simcere Zaiming","url":"https://stock-news.laohu8.com/highlight/detail?id=2602112371","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602112371?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:10","pubTimestamp":1767967836,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA051:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"1156422815","title":"Guojin Securities Initiates Coverage on Simcere Pharma (02096) with \"Buy\" Rating, Targets HK$20.16","url":"https://stock-news.laohu8.com/highlight/detail?id=1156422815","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156422815?lang=en_us&edition=fundamental","pubTime":"2025-12-29 10:16","pubTimestamp":1766974605,"startTime":"0","endTime":"0","summary":"Guojin Securities issued a research report stating that Simcere Pharma (02096) exhibits strong growth certainty, driven by the simultaneous resonance of short-term pipeline product launches and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1583","BK1191"],"gpt_icon":0},{"id":"1166988588","title":"Securing a $7.4 Billion Mega-Deal, $17 Billion Pharma Tycoon Ren Jinsheng is on a Winning Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=1166988588","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166988588?lang=en_us&edition=fundamental","pubTime":"2025-12-25 23:01","pubTimestamp":1766674905,"startTime":"0","endTime":"0","summary":"Innovative pharmaceutical player SIMCERE PHARMA (02096.HK), with a market cap of over 30 billion yuan, recently secured a massive order potentially worth up to $1.06 billion (approximately 7.4...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2593309492","title":"Simcere Pharma Gets China Nod for Tumor Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2593309492","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593309492?lang=en_us&edition=fundamental","pubTime":"2025-12-23 19:43","pubTimestamp":1766490200,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical (HKG:2096) obtained approval to conduct clinical trials of SIM0610 from China's National Medical Products Administration, a Tuesday Hong Kong bourse filing said.The pharma firm intends to evaluate the drug to treat patients with locally advanced or metastatic solid tumors.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"1138051402","title":"SIMCERE PHARMA (02096): SIM0610 (EGFR/cMET Bispecific Antibody-Drug Conjugate) Receives Clinical Trial Approval from NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1138051402","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138051402?lang=en_us&edition=fundamental","pubTime":"2025-12-23 17:24","pubTimestamp":1766481875,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) announced that its self-developed bispecific antibody-drug conjugate (BsADC) candidate, SIM0610, has received clinical trial approval from China's National Medical Products...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2593349301","title":"Simcere Pharmaceutical - Sim0610 Receives Clinical Trial Approval From Nmpa China","url":"https://stock-news.laohu8.com/highlight/detail?id=2593349301","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593349301?lang=en_us&edition=fundamental","pubTime":"2025-12-23 17:16","pubTimestamp":1766481361,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT08D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02096","BK1583","BK1191"],"gpt_icon":0},{"id":"2593093493","title":"Simcere Pharmaceutical Group Receives China Approval to Begin Clinical Trials for SIM0610 Bispecific Antibody-Drug Conjugate","url":"https://stock-news.laohu8.com/highlight/detail?id=2593093493","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593093493?lang=en_us&edition=fundamental","pubTime":"2025-12-23 17:15","pubTimestamp":1766481343,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Ltd. announced that its independently developed bispecific antibody-drug conjugate, SIM0610, has received Clinical Trial Approval from the National Medical Products Administration of China. SIM0610, which targets both EGFR and cMET, is set to be evaluated in patients with locally advanced or metastatic solid tumors. The approval marks a significant milestone in Simcere’s ongoing efforts in oncology drug development. No other organizations are mentioned as recipients of this approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL7HGwv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"1146574184","title":"Hong Kong Stock Announcement Highlights | Sanhua Intelligent Controls Issues Profit Alert with Expected Annual Net Profit Growth of 25%-50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146574184","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146574184?lang=en_us&edition=fundamental","pubTime":"2025-12-22 23:05","pubTimestamp":1766415912,"startTime":"0","endTime":"0","summary":"**Key Developments**:   - SIMCERE PHARMA (02096) subsidiary signed an exclusive licensing agreement with Ipsen for SIM0613 (LRRC15 antibody-drug conjugate).   - CloudMinds (09678) launched the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00293","LU2580892862.HKD","LU1064130708.USD","BK0028","BK1583","BK0259","LU2238339852.HKD","02096","LU2148510915.USD","LU1023057109.AUD","LU1328615791.USD","SGXZ49509284.SGD","BK0187","BK0070","LU1064131003.USD","SGXZ81163826.USD","BK1561","BK1183","LU1969619763.USD","LU0359202008.SGD","02050","002050","LU2298064838.USD","LU0359201612.USD","BK0188","LU2328871848.SGD","BK1123","BK0076","BK1191","BK0197","LU1939255532.USD","LU2580892789.USD"],"gpt_icon":0},{"id":"1162165653","title":"SIMCERE PHARMA (02096) Subsidiary Enters Exclusive Licensing Agreement with Ipsen for SIM0613 (LRRC15-Targeting ADC)","url":"https://stock-news.laohu8.com/highlight/detail?id=1162165653","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162165653?lang=en_us&edition=fundamental","pubTime":"2025-12-22 12:20","pubTimestamp":1766377200,"startTime":"0","endTime":"0","summary":"On December 19, 2025, SIMCERE PHARMA (02096) announced that its subsidiary, Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd., entered an exclusive licensing agreement with Ipsen Pharma SAS (Euronext:...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2593103177","title":"Simcere Pharmaceutical - Ipsen to Have Exclusive Global Rights for Sim0613","url":"https://stock-news.laohu8.com/highlight/detail?id=2593103177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593103177?lang=en_us&edition=fundamental","pubTime":"2025-12-22 12:09","pubTimestamp":1766376575,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XR00M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","02096","BK1191"],"gpt_icon":0},{"id":"2593031721","title":"Simcere Pharmaceutical - Unit Enters Licensing Agreement With Ipsen Pharma Sas","url":"https://stock-news.laohu8.com/highlight/detail?id=2593031721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593031721?lang=en_us&edition=fundamental","pubTime":"2025-12-22 12:09","pubTimestamp":1766376558,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XR00L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2593031081","title":"Simcere Pharmaceutical -Under Group, Group Eligible to Receive up to US$1,060 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2593031081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593031081?lang=en_us&edition=fundamental","pubTime":"2025-12-22 12:09","pubTimestamp":1766376558,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XR00L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02096","BK1191","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.simcere.com","stockEarnings":[{"period":"1week","weight":-0.0272},{"period":"1month","weight":-0.0984},{"period":"3month","weight":-0.0787},{"period":"6month","weight":-0.0215},{"period":"1year","weight":0.7879},{"period":"ytd","weight":-0.0125}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":0.031},{"period":"3month","weight":0.0274},{"period":"6month","weight":0.032},{"period":"1year","weight":0.3293},{"period":"ytd","weight":0.0334}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.091371},{"month":2,"riseRate":0.6,"avgChangeRate":0.07279},{"month":3,"riseRate":0.4,"avgChangeRate":-0.021724},{"month":4,"riseRate":0.6,"avgChangeRate":0.009116},{"month":5,"riseRate":0.8,"avgChangeRate":0.158743},{"month":6,"riseRate":0.6,"avgChangeRate":0.036684},{"month":7,"riseRate":0.2,"avgChangeRate":-0.0521},{"month":8,"riseRate":0.4,"avgChangeRate":-0.05132},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0324},{"month":10,"riseRate":0.8,"avgChangeRate":0.108781},{"month":11,"riseRate":0.666667,"avgChangeRate":0.044275},{"month":12,"riseRate":0.5,"avgChangeRate":0.000552}],"exchange":"SEHK","name":"SIMCERE PHARMA","nameEN":"SIMCERE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SIMCERE PHARMA(02096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SIMCERE PHARMA(02096) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SIMCERE PHARMA,02096,SIMCERE PHARMA股票,SIMCERE PHARMA股票老虎,SIMCERE PHARMA股票老虎国际,SIMCERE PHARMA行情,SIMCERE PHARMA股票行情,SIMCERE PHARMA股价,SIMCERE PHARMA股市,SIMCERE PHARMA股票价格,SIMCERE PHARMA股票交易,SIMCERE PHARMA股票购买,SIMCERE PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SIMCERE PHARMA(02096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SIMCERE PHARMA(02096) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}